The National Basketball Association (NBA) recently released a memo stating that it won’t be testing its athletes for cannabis for the entirety of the upcoming season.
“We have agreed with the NBPA to extend the suspension of random testing for marijuana for the 2021-22 season and focus our random testing program on performance-enhancing products and drugs of abuse,” Bass stated.
NBA players were given a memo about the news, but ESPN was the first to obtain the memo and report the information, as of a statement from ESPN Senior NBA Insider Adrian Wojnarowski.
“Players won’t be subject to random tests for marijuana this season,” according to @NBPA memo shared with players and obtained by ESPN. That’s been adjusted policy through Orlando restart and 2020-‘21 season. Testing continues for “drugs of abuse and performance enhancing substances,” he shared on Twitter.
The NBA first announced that it would suspend random drug tests for cannabis in March 2020, back when the pandemic was ramping up. According to the Associated Press, testing resumed later in summer 2020 at the Orlando Bubble to check for performance-enhancing substances—but cannabis wasn’t among the substances athletes were tested for, mainly in an effort to reduce unnecessary contact for players.
Reporter Ben Dowsett was among the first to confirm this change through league sources later last year, which he shared in a Twitter post in December 2020.
“Sources say this decision is largely based on COVID safety–just another way of limiting unnecessary contacts. However, there’s also significant expectation from many in the league that the entire marijuana testing program is on the way out in the near future.”
It is still a possibility that the NBA could eventually decide to end testing for cannabis permanently, although no official announcement has been made. Cannabis wasn’t included on the list of testable substances in the last NBA season, and now it is confirmed that cannabis will again not be tested for by athletes in this current season as well.
There are many factors that can be attributed to the NBA agreeing to halt cannabis testing for athletes, but one of the reasons is because of athletes speaking out in favor of cannabis and its efficacy as a medicine. Countless athletes have spoken up, and many of them have started their own cannabis businesses, such as former NBA athlete Chris Webber. His company, Players Only Holdings, recently broke ground on a $50 million production and training facility in Detroit Michigan. Another former NBA player, Kevin Durant, used his company Thirty Five Ventures to partner with Weedmaps in an effort to fight the stigma against cannabis.
The news of running athlete Sha’Carri Richardson testing positive for cannabis, resulting in her disqualification in the Tokyo Olympics, made global headlines as well. The outroar garnered intense support for her situation from many sources, including the White House and U.S. Anti-Doping Agency, as well as U.S. state legislators.
Tennessee Congressman Steven Cohen joked that cannabis is a performance-enhancing substance in only one case. “Marijuana is not a performance-enhancing drug unless you’re entered in the Coney Island hot dog eating contest on the Fourth of July,” Cohen said in July.
Other sports organizations have also begun to loosen restrictions on cannabis consumption. In April, the National Football League announced that it would no longer test for cannabis during the offseason. In December 2019, the Major League Baseball association announced that it would remove cannabis from its list of abused drugs and would only continue to test athletes for opioids and cocaine.
The post NBA Won’t Randomly Test Athletes for Cannabis During 75th Season appeared first on High Times.